DTC Genetic Testing in 2026: Complete Buyer's Guide (Post-23andMe Era)

23andMe's 2025 bankruptcy fundamentally changed the direct-to-consumer (DTC) genetic testing landscape. With 15+ million users' data in limbo and a fragmented market of alternatives, choosing a DTC genetic test in 2026 is more complicated than ever.

This guide is the result of 6 months researching every major DTC service still operating in 2026 — comparing accuracy, data privacy practices, what reports actually contain, and which services are worth your money (and DNA).

TL;DR:

• For ancestry: AncestryDNA (largest reference database)
• For health insights: MyHeritage Health or Tellmegen
• For whole genome sequencing: Nebula Genomics or Dante Labs
• For Korean users: Macrogen DNA Care or Theragen Etex
• For raw data control: Nebula (encrypted), Dante (downloadable VCF)
• Avoid: Services without clear data deletion policies, "alpha" tier with limited reports

⚠️ Critical disclaimer: DTC genetic tests are NOT clinical diagnostic tools. They provide probabilistic information that requires careful interpretation. For medical decisions, consult a qualified genetic counselor. See our Medical Disclaimer.

What Happened to 23andMe?

In March 2025, 23andMe filed for Chapter 11 bankruptcy after years of declining sales and a major 2023 data breach that exposed 6.9 million users' information. The company's database — containing genetic profiles of ~15 million customers — has been the subject of intense legal scrutiny regarding:

• Sale of customer data as part of bankruptcy assets
• Anne Wojcicki's repurchase attempts
• Customer rights to delete data
• Cross-border data transfer concerns

For existing 23andMe customers:

• Your account may still work, but data ownership is uncertain
• You can (and should) download your raw DNA data while possible
• You can request deletion via the still-functional account portal
• Lawsuits regarding pre-bankruptcy promises continue

Lesson for choosing a new service: Data ownership policies and bankruptcy protections matter more than people previously thought.

The 10 Major DTC Services in 2026

Comparison Matrix

Service	Type	Price (2026)	Reports	Raw Data Access	Best For
AncestryDNA	Autosomal microarray	$99	Ancestry only	✅ Download	Genealogy, family matching
MyHeritage DNA	Autosomal microarray	$89	Ancestry + health add-on	✅ Download	International ancestry
MyHeritage Health	+ Health analysis	$199	18 conditions, 13 carrier status	✅ Download	Combined ancestry + health
Tellmegen	Microarray (700K SNPs)	$189	400+ reports including pharmacogenomics	✅ Full download	Comprehensive single-test
Nebula Genomics	30x WGS	$299-499	Ancestry + extensive reports + raw VCF	✅ Encrypted, blockchain	Privacy + scientific depth
Dante Labs	30x WGS	$399	Comprehensive + downloadable BAM/VCF	✅ Full raw access	Researchers, completeness
MapMyGenome	Microarray	$299	100+ reports, pharmacogenomics emphasis	✅ Download	Indian/South Asian populations
Macrogen DNA Care	Microarray	₩330,000	Korean-specific reports	✅ Korean format	Korean users
Theragen Etex GENEINSIDE	Microarray	₩300,000	Korean health + ancestry	⚠️ Limited	Korean market
CircleDNA Premium	WGS panel	$379	500+ reports, lifestyle focused	✅ Download	Lifestyle/wellness focus

Why Technology Matters: Microarray vs Whole Genome

Microarray (chip-based):
- Reads ~700,000 specific SNPs (single nucleotide polymorphisms)
- Covers ~0.02% of the genome
- Fast, cheap, sufficient for ancestry and common variants
- Cannot detect rare variants, structural variations, or de novo mutations
- Used by: 23andMe (was), AncestryDNA, MyHeritage, Tellmegen, MapMyGenome

Whole Genome Sequencing (WGS):
- Reads essentially the entire genome (~3 billion bases)
- 30x coverage = each base read ~30 times for accuracy
- Detects rare variants, copy number variations, structural rearrangements
- More expensive but future-proof
- Used by: Nebula, Dante Labs, some research-grade services
- Output: ~200 GB raw data per person

Exome sequencing (middle ground):
- Sequences only protein-coding regions (~1-2% of genome)
- Better than microarray for medical relevance
- Cheaper than WGS
- Used by some clinical labs, fewer DTC options

For most consumers: Microarray is sufficient. For serious health analysis or future-proofing: WGS is worth the extra cost.

Service Deep Dives

AncestryDNA — The Genealogy Standard

Strengths:

• Largest reference database (~25 million users)
• Best DNA matching with relatives (often 1000+ matches per user)
• Excellent ancestry breakdown (especially European, North American populations)
• Integration with Ancestry's family tree platform
• Most mature interface and tools

Weaknesses:

• No health reports (must export raw data and analyze elsewhere)
• Microarray limitations
• Asian, African, Indigenous ancestry less detailed than European
• Pricing creep (was $79, now $99 standard, often more)

Privacy:

• Comprehensive privacy controls (can opt out of research, family matching)
• Data deletion process works (but research data may persist anonymized)
• US-based, subject to US data laws
• No genetic data sale to insurers/employers (per stated policy)

Best for: Genealogy hobbyists, family history research, finding relatives

MyHeritage DNA — The International Alternative

Strengths:

• Strong European, Middle Eastern, Sephardic Jewish ancestry detection
• Excellent international reach (especially Israel, Eastern Europe)
• Strong family matching
• Can upload raw data from other services
• Health add-on available

Weaknesses:

• Database smaller than Ancestry (~6 million)
• Subscription required for many advanced features ($99-189/year)
• Health analysis less comprehensive than Tellmegen

Privacy:

• Israel-based, EU GDPR compliant
• Clear data deletion process
• More transparent about data partnerships than 23andMe was

Tellmegen — The Comprehensive Choice

Strengths:

• 400+ reports including pharmacogenomics (drug response)
• Spanish company, EU GDPR compliant
• Single test, lifetime updates as new research emerges
• Strong on rare disease carrier status
• Pharmacogenomics reports clinically useful

Weaknesses:

• Less ancestry depth than dedicated genealogy services
• Smaller user base = fewer relative matches
• Interface less polished than competitors
• Reports can be overwhelming for non-scientists

Privacy:

• EU-based, strong data protection
• No data sharing for research without explicit consent
• Account deletion straightforward

Best for: Users wanting maximum health information from a single test, especially pharmacogenomic insights

Nebula Genomics — Privacy-First Whole Genome

Strengths:

• True whole genome sequencing (not microarray)
• Blockchain-based access logs (you see who queries your data)
• Encrypted storage with user-controlled access keys
• "Subscription science" — new reports as research emerges
• Anonymous purchase options
• Founded by George Church (Harvard genetics pioneer)

Weaknesses:

• More expensive ($299-499 depending on tier)
• Longer turnaround (4-8 weeks)
• Interface more technical
• Health reports less polished than 23andMe-era

Privacy: Industry-leading. The blockchain access control is genuinely novel.

Best for: Users prioritizing data control, scientific accuracy, future research applications

Dante Labs — WGS with Raw Data Freedom

Strengths:

• 30x WGS with downloadable raw data (BAM, FASTQ, VCF formats)
• Italian/EU-based with strong GDPR compliance
• Researcher-friendly raw data access
• Various report tiers
• Often runs promotions ($199-299)

Weaknesses:

• Inconsistent customer service reports
• Turnaround times variable (some reports of 3+ months)
• Reports themselves less polished than dedicated DTC services

Privacy: Strong. EU-based, user controls raw data.

Best for: Researchers, bioinformaticians, anyone who wants to run their own analyses on raw genomic data

Korean Services: Macrogen vs Theragen Etex

For Korean users or those interested in Korean-specific analysis:

Macrogen DNA Care (마크로젠)

• Korean genetics market leader
• Reports include Korean population-specific risks
• ₩330,000 standard
• Includes obesity, cancer risk, ancestry
• Hospital partnerships for clinical follow-up

Theragen Etex GENEINSIDE (테라젠이텍스)

• Strong nutrigenomics emphasis
• Korean-specific traits (alcohol metabolism, etc.)
• ₩300,000
• Mobile-first app interface

Comparison:

• Macrogen has stronger medical reputation
• Theragen has better consumer interface
• Both serve Korean population well
• Both limited compared to international WGS options

What DTC Tests Actually Tell You (And Don't)

The marketing often suggests DTC tests can predict your health future. Reality is more nuanced.

What DTC Tests Do Well

Ancestry (✅ Reliable):

• Continental ancestry: 90%+ accurate
• Country-level: 70-85% accurate
• Sub-population: 50-70% accurate
• Migration patterns: well-established
• Y-chromosome and mitochondrial lineages: very accurate

Carrier Status for Mendelian Diseases (✅ Useful):

• Cystic fibrosis, Tay-Sachs, sickle cell, etc.
• Single-gene conditions with well-characterized variants
• Useful for family planning decisions
• Should be confirmed with clinical testing if positive

Pharmacogenomics (✅ Useful for Some):

• Warfarin sensitivity (CYP2C9, VKORC1)
• Clopidogrel response (CYP2C19)
• Codeine metabolism (CYP2D6)
• Useful information to share with prescribing physicians
• NOT a replacement for clinical PGx testing

Trait predictions (✅ Mostly Reliable):

• Eye color, hair color
• Lactose tolerance
• Alcohol flushing (especially ALDH2 variants in East Asians)
• Caffeine metabolism rate

What DTC Tests Do Poorly

Complex Disease Risk (⚠️ Limited):

• Type 2 diabetes, heart disease, Alzheimer's
• Polygenic risk scores (PRS) only explain small fraction of risk
• Lifestyle and environment matter much more
• Easy to misinterpret elevated PRS as "destiny"

Cancer Risk (⚠️ Be Careful):

• BRCA1/BRCA2 reported by some services, but only common variants
• Missing rare pathogenic variants → false reassurance
• Negative DTC test ≠ "you're safe" for cancer

Mental Health (❌ Largely Unreliable):

• Depression, anxiety, ADHD "predictions" mostly speculative
• Polygenic scores explain <5% of variance
• Strong potential for harm if misinterpreted

Nutrition / "Optimal Diet" Predictions (❌ Largely Marketing):

• "Personalized diet based on your DNA" claims are mostly oversold
• Few diet-gene interactions are well-validated
• Generic healthy diet advice usually outperforms "DNA diet"

Athletic Performance / "Sports Gene" Tests (❌ Pseudoscientific):

• ACTN3 "speed gene" — small effect, doesn't predict elite performance
• Marketing far exceeds science
• Training and nutrition matter much more

Data Privacy: What You're Actually Risking

The 23andMe Lesson

23andMe's bankruptcy revealed risks people hadn't fully considered:

1. Company changes hands: Your data becomes a saleable asset
2. Privacy policies are not permanent: Can change with new ownership
3. "Anonymized" data isn't truly anonymous: With enough markers, re-identification is feasible
4. Family members are affected too: Your DNA reveals information about relatives who didn't consent
5. Insurance and employment: While GINA protects some uses in the US, exceptions exist (life insurance, long-term care)

Privacy Best Practices for DTC Testing

Before testing:
□ Read the full privacy policy (not just summary)
□ Verify the company's deletion process
□ Check data sharing partnerships
□ Understand what happens if company is sold
□ Consider using pseudonym + anonymous payment

During testing:
□ Opt out of research participation if available
□ Decline family matching if privacy is paramount
□ Disable third-party app integrations
□ Use unique email address for the account

After testing:
□ Download your raw data immediately
□ Store raw data securely (encrypted external drive)
□ Periodically review consent settings
□ Delete account if you no longer need it

Korea-Specific Privacy Considerations

For Korean users:

• Personal Information Protection Act (PIPA) provides strong protection
• DTC genetic testing is regulated by Bioethics and Safety Act
• Korean services must comply with both
• Cross-border data transfer (using international services) carries additional risks
• Genetic discrimination not explicitly prohibited in employment (gap in law)

How to Analyze Your Raw DNA Data (Free Tools)

Once you have raw DNA data from any service, you can re-analyze it with free tools that often provide better insights than the original reports.

Step 1: Download Your Raw Data

Each service has different format. Common ones:

• 23andMe format: tab-separated text file, ~700K SNPs
• AncestryDNA format: similar but slightly different column order
• VCF format: standard variant call format (from WGS services)

Step 2: Free Analysis Tools

Promethease (No longer accepting new uploads as of 2024 — RIP)
Status: Defunct, but worth mentioning as historical context

GEDmatch:
- Free ancestry tools and DNA comparison
- Strong genealogy community
- Has been used by law enforcement (privacy consideration)

DNA.land:
- Free third-party analysis
- Health and ancestry reports
- Pause periods due to funding

Genetic Genealogy Standards:
- Codis-style tools for genealogy
- Free public projects

ImputeMe (Lasse Folkersen):
- Free polygenic risk score analysis
- 100+ health traits
- Academic-grade research

GenoMate:
- Newer service
- Free tier available
- Health reports based on uploaded data

Kruta:
- Korean-focused analysis
- Korean variant interpretations

Step 3: Population-Specific Databases

For better interpretation:

• gnomAD: Population frequency database
• ClinVar: Clinical variant interpretations
• dbSNP: SNP catalog
• SNPedia (deprecated but historical): Variant interpretations
• K1000G: Korean reference genome data

Decision Framework: Which Test Should You Get?

Step 1: Why do you want to test?

A) Pure ancestry interest → AncestryDNA or MyHeritage
B) Health insights → Tellmegen, MyHeritage Health, or WGS
C) Family planning → Tellmegen (carrier status) + clinical confirmation
D) Pharmacogenomics → Tellmegen, or ask doctor for clinical PGx
E) Research / data ownership → Nebula or Dante Labs WGS
F) Korean-specific → Macrogen or Theragen Etex
G) "Just curious" → Pick cheapest reputable option

Step 2: How important is data privacy?

Maximum privacy: Nebula Genomics (blockchain controls)
Strong privacy: EU-based services (Tellmegen, Dante, MyHeritage)
Standard privacy: AncestryDNA, Korean services
Lower privacy: Avoid newer/smaller services without clear policies

Step 3: Budget?

Under $100: AncestryDNA, MyHeritage basic
$100-200: MyHeritage Health, Tellmegen
$200-400: Nebula tiers, Dante Labs, CircleDNA
Korean: ₩300,000 standard

Step 4: Microarray or WGS?

Microarray is fine if:
- Primarily ancestry interest
- Casual health curiosity
- Budget-conscious
- Common diseases focus

WGS worth it if:
- Rare disease in family
- Future scientific reanalysis valuable
- Research interest
- Long-term data investment

Common Mistakes People Make with DTC Tests

Mistake 1: Treating Results as Diagnostic

DTC tests use lower-stringency analyses than clinical labs. A "positive" BRCA1 finding from 23andMe needs clinical confirmation. A "low risk" finding doesn't mean zero risk.

Mistake 2: Acting on Polygenic Risk Scores

PRS for complex diseases (diabetes, heart disease) explain 1-10% of variance. Your lifestyle factors explain far more. Don't let an "elevated" PRS create unnecessary anxiety or false reassurance.

Mistake 3: Ignoring Reference Population Bias

Most variant databases are built on European populations. If you're East Asian, African, Latin American, or mixed ancestry, many disease risk estimates are less accurate. Korean-specific services like Macrogen address this for Korean users.

Mistake 4: Sharing Data Recklessly

Once your DNA data is on third-party platforms, you've lost some control. Be selective about which services you upload raw data to.

Mistake 5: Not Telling Family

Your genetic information is also (partially) about your relatives. Discovering a BRCA mutation or carrier status affects siblings, parents, and children. Consider their interests before testing.

Mistake 6: Assuming "More Reports = Better"

A service with 500 reports may have hundreds of speculative claims alongside the well-validated ones. More reports with weaker evidence isn't necessarily better than fewer high-quality reports.

Frequently Asked Questions

Q: Should I still trust 23andMe results I already have?

Your raw DNA data is still valid (DNA doesn't change). The interpretive reports were good when published. The question is what happens to your data going forward — download raw data, then delete account if concerned about future ownership.

Q: Can my genetic data be used against me by insurance?

In the US, GINA (Genetic Information Nondiscrimination Act) protects against health insurance and employment discrimination, but does NOT protect against life insurance, disability insurance, or long-term care insurance discrimination. In Korea, legal protections exist but are less comprehensive.

Q: How accurate are ancestry results?

Continental-level (European, Asian, African): >90% accurate. Country-level (Korean vs Japanese vs Chinese): 70-85% depending on database depth. Sub-regional (specific Korean province): typically not reliably distinguishable due to historical migration.

Q: Can DTC tests detect rare cancers I should worry about?

DTC tests check common cancer-related variants but miss most rare pathogenic variants. A negative result is NOT reassurance against cancer risk. If you have strong family history, get clinical testing (not DTC).

Q: What's the difference between DTC tests and clinical genetic testing?

Clinical: Higher analytical accuracy, validated for medical decisions, CAP/CLIA certified labs, requires physician order, covered by insurance for medical necessity. DTC: Lower stringency, not designed for medical decisions, no physician oversight, pay out of pocket. DTC is for curiosity and screening; clinical is for diagnosis.

Q: How long does DTC testing take?

Typical timelines:

• Microarray services (AncestryDNA, MyHeritage): 4-8 weeks
• WGS services (Nebula, Dante): 6-12 weeks
• Korean services: 3-6 weeks

Q: Can DTC tests tell me about ADHD, autism, or other neurodevelopmental conditions?

Some services claim to. The science doesn't yet support reliable predictions. Polygenic scores for these conditions are not yet useful clinically.

Q: Should children get DTC genetic testing?

Generally not recommended. Major medical organizations (American Academy of Pediatrics, American College of Medical Genetics) advise against DTC testing for minors except for specific medical reasons. Wait until they can consent themselves.

Q: What about "personalized nutrition" from DTC tests?

Largely oversold. A few variants (lactose tolerance via LCT, alcohol metabolism via ADH1B/ALDH2, MTHFR for folate) have some validity. Most "personalized diet" recommendations exceed the science. See our Nutrigenomics: Science or Marketing? for deeper analysis.

Q: How do I download raw data from each service?

• AncestryDNA: Settings → DNA → Download Raw DNA Data
• MyHeritage: Settings → DNA → Download Raw Data
• 23andMe: Account Settings → Browse Raw Data → Download
• Tellmegen: Available in account portal
• Nebula: Encrypted access, download via portal with your key
• Dante Labs: Raw BAM/VCF/FASTQ files in account

Q: What's the most useful thing I can do with raw DNA data?

1. Upload to ImputeMe for academic-grade polygenic score analysis
2. Check pharmacogenomic variants for your medications (using PharmGKB)
3. Verify Mendelian disease carrier status
4. Build genealogy tree with GEDmatch
5. Contribute to ethical research (e.g., All of Us Research Program)

Q: I'm Korean — should I use Korean or international services?

If accuracy in Korean ancestry detail matters most: Korean services (Macrogen, Theragen). If broader features (more reports, pharmacogenomics, etc.) matter: International services + supplement with Korean reference data via free tools.

Q: How often should I retest?

Generally no need. Your DNA doesn't change. New interpretations may emerge — you can re-analyze the same raw data periodically without re-testing.

Q: What about embryo / prenatal genetic testing?

That's a different category entirely — clinical genetics. DTC services are NOT appropriate for prenatal decisions. Consult an OB-GYN or genetic counselor for clinical testing.

Q: Can I afford DTC testing on a limited budget?

The most useful for budget: AncestryDNA on sale (often $59-79) gives you raw data for free third-party analysis. You get more useful info via free third-party tools than from the AncestryDNA reports themselves.

Q: What if I want maximum data without buying a test?

Look at:

• All of Us Research Program (US): Free WGS for research participants
• UK Biobank (UK): Research-grade data for participants
• Korean Biobank Network: Research participation opportunities
• OpenSNP: Public genetic data sharing project

Related Articles

For deeper dives on specific genetic testing topics:

• 23andMe Alternatives in Korea (2026) — Korean market deep dive
• DTC Genetic Test Results: Complete Interpretation Guide — How to read your results
• Nutrigenomics: Personalized Diet Guide — What nutrigenomics can actually deliver
• Nutrigenomics: Science or Marketing? — Critical analysis of personalized nutrition claims

---

Last updated: May 2026. The DTC genetic testing landscape is evolving rapidly post-23andMe bankruptcy. This guide is updated quarterly. Bookmark and check back.

This guide is for educational purposes only and not medical advice. Always consult a qualified genetic counselor or physician for medical decisions based on genetic information. See Medical Disclaimer for full details.